US Stock MarketDetailed Quotes

NUGX NUGENEREX IMMUNO-ONCOLOGY INC

Watchlist
  • 0.000100
  • 0.0000000.00%
15min DelayClose May 24 09:30 ET
10.03KMarket Cap0.00P/E (TTM)

NUGENEREX IMMUNO-ONCOLOGY INC Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Apr 30, 2021
(Q2)Jan 31, 2021
(Q1)Oct 31, 2020
(FY)Jul 31, 2020
(Q4)Jul 31, 2020
(Q3)Apr 30, 2020
(Q2)Jan 31, 2020
(Q1)Oct 31, 2019
(FY)Jul 31, 2019
(Q4)Jul 31, 2019
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
1,813.60%1.7M
2,092.81%1.83M
2,067.74%1.5M
86.79%733.61K
5,796.52%277.79K
253.96%88.71K
-75.63%83.55K
69.19K
392.74K
4.71K
Selling and administrative expenses
613.61%633.04K
517.34%494.18K
1,805.84%606.13K
768.06%336.3K
2,781.15%135.73K
253.96%88.71K
8,874.22%80.05K
--31.8K
--38.74K
--4.71K
-General and administrative expense
613.61%633.04K
517.34%494.18K
1,805.84%606.13K
768.06%336.3K
2,781.15%135.73K
253.96%88.71K
8,874.22%80.05K
--31.8K
--38.74K
--4.71K
Research and development costs
--1.06M
38,126.26%1.34M
2,290.57%893.64K
12.24%397.32K
--142.05K
--0
-98.98%3.5K
--37.38K
--354K
--0
Operating profit
-1,813.60%-1.7M
-2,092.81%-1.83M
-2,067.74%-1.5M
-86.79%-733.61K
-5,796.52%-277.79K
-253.96%-88.71K
75.63%-83.55K
-69.19K
-392.74K
-4.71K
Net non-operating interest income expense
-19.56%-261.07K
-19.56%-249.67K
-19.56%-238.76K
-19.56%-855.2K
-19.56%-228.32K
-19.56%-218.36K
-19.56%-208.82K
-199.7K
-715.28K
-190.97K
Non-operating interest expense
19.56%261.07K
19.56%249.67K
19.56%238.76K
19.56%855.2K
19.56%228.32K
19.56%218.36K
19.56%208.82K
--199.7K
--715.28K
--190.97K
Other net income (expense)
Income before tax
-537.84%-1.96M
-612.04%-2.08M
-546.58%-1.74M
-43.39%-1.59M
-158.64%-506.11K
-47.85%-307.07K
43.51%-292.37K
-268.88K
-1.11M
-195.68K
Income tax
Net income
-537.84%-1.96M
-612.04%-2.08M
-546.58%-1.74M
-43.39%-1.59M
-158.64%-506.11K
-47.85%-307.07K
43.51%-292.37K
-268.88K
-1.11M
-195.68K
Net income continuous Operations
-537.84%-1.96M
-612.04%-2.08M
-546.58%-1.74M
-43.39%-1.59M
-158.64%-506.11K
-47.85%-307.07K
43.51%-292.37K
---268.88K
---1.11M
---195.68K
Minority interest income
Net income attributable to the parent company
-537.84%-1.96M
-612.04%-2.08M
-546.58%-1.74M
-43.39%-1.59M
-158.64%-506.11K
-47.85%-307.07K
43.51%-292.37K
-268.88K
-1.11M
-195.68K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-537.84%-1.96M
-612.04%-2.08M
-546.58%-1.74M
-43.39%-1.59M
-158.64%-506.11K
-47.85%-307.07K
43.51%-292.37K
-268.88K
-1.11M
-195.68K
Basic earnings per share
-553.17%-0.02
-612.01%-0.0208
-546.51%-0.0173
-43.40%-0.0158
-158.64%-0.005
-47.85%-0.0031
43.51%-0.0029
-0.0027
-0.011
-0.002
Diluted earnings per share
-553.17%-0.02
-612.01%-0.0208
-546.51%-0.0173
-43.40%-0.0158
-158.64%-0.005
-47.85%-0.0031
43.51%-0.0029
-0.0027
-0.011
-0.002
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Apr 30, 2021(Q2)Jan 31, 2021(Q1)Oct 31, 2020(FY)Jul 31, 2020(Q4)Jul 31, 2020(Q3)Apr 30, 2020(Q2)Jan 31, 2020(Q1)Oct 31, 2019(FY)Jul 31, 2019(Q4)Jul 31, 2019
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 1,813.60%1.7M2,092.81%1.83M2,067.74%1.5M86.79%733.61K5,796.52%277.79K253.96%88.71K-75.63%83.55K69.19K392.74K4.71K
Selling and administrative expenses 613.61%633.04K517.34%494.18K1,805.84%606.13K768.06%336.3K2,781.15%135.73K253.96%88.71K8,874.22%80.05K--31.8K--38.74K--4.71K
-General and administrative expense 613.61%633.04K517.34%494.18K1,805.84%606.13K768.06%336.3K2,781.15%135.73K253.96%88.71K8,874.22%80.05K--31.8K--38.74K--4.71K
Research and development costs --1.06M38,126.26%1.34M2,290.57%893.64K12.24%397.32K--142.05K--0-98.98%3.5K--37.38K--354K--0
Operating profit -1,813.60%-1.7M-2,092.81%-1.83M-2,067.74%-1.5M-86.79%-733.61K-5,796.52%-277.79K-253.96%-88.71K75.63%-83.55K-69.19K-392.74K-4.71K
Net non-operating interest income expense -19.56%-261.07K-19.56%-249.67K-19.56%-238.76K-19.56%-855.2K-19.56%-228.32K-19.56%-218.36K-19.56%-208.82K-199.7K-715.28K-190.97K
Non-operating interest expense 19.56%261.07K19.56%249.67K19.56%238.76K19.56%855.2K19.56%228.32K19.56%218.36K19.56%208.82K--199.7K--715.28K--190.97K
Other net income (expense)
Income before tax -537.84%-1.96M-612.04%-2.08M-546.58%-1.74M-43.39%-1.59M-158.64%-506.11K-47.85%-307.07K43.51%-292.37K-268.88K-1.11M-195.68K
Income tax
Net income -537.84%-1.96M-612.04%-2.08M-546.58%-1.74M-43.39%-1.59M-158.64%-506.11K-47.85%-307.07K43.51%-292.37K-268.88K-1.11M-195.68K
Net income continuous Operations -537.84%-1.96M-612.04%-2.08M-546.58%-1.74M-43.39%-1.59M-158.64%-506.11K-47.85%-307.07K43.51%-292.37K---268.88K---1.11M---195.68K
Minority interest income
Net income attributable to the parent company -537.84%-1.96M-612.04%-2.08M-546.58%-1.74M-43.39%-1.59M-158.64%-506.11K-47.85%-307.07K43.51%-292.37K-268.88K-1.11M-195.68K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -537.84%-1.96M-612.04%-2.08M-546.58%-1.74M-43.39%-1.59M-158.64%-506.11K-47.85%-307.07K43.51%-292.37K-268.88K-1.11M-195.68K
Basic earnings per share -553.17%-0.02-612.01%-0.0208-546.51%-0.0173-43.40%-0.0158-158.64%-0.005-47.85%-0.003143.51%-0.0029-0.0027-0.011-0.002
Diluted earnings per share -553.17%-0.02-612.01%-0.0208-546.51%-0.0173-43.40%-0.0158-158.64%-0.005-47.85%-0.003143.51%-0.0029-0.0027-0.011-0.002
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------
Heat List
US
Overall
Symbol
Price
% Chg

No Data